KevinMD January 16, 2024
Yongjia Wang

In 2020, the ICPerMed (International Consortium for Personalized Medicine) published a ten-year vision for how personalized medicine, a new form of medicine, has the potential to rebuild an equitable and accessible health care system by 2030.

Precision or personalized medicines are drugs developed with genomic sequencing technologies, targeting the critical genes in specific types of cancer or genetic diseases. Thus, PMs are highly effective in treating their targeted patients, sometimes buying patients years compared to other standard treatments.

Since the Human Genome Project’s (HGP) release of the human genome sequence in 2003 and President Obama’s 216 million dollar PM initiative in 2016, more and more scientists and pharmaceutical companies are focusing on this new field.

As a pre-med student who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute
Largest GWAS for Breast Cancer in Women of African Ancestry Reveals Key Variants
New Study Links Ribosomal DNA Copy Number with Disease Risk
Navigating the Complexities of Payment for Genetic Testing

Share This Article